1997
DOI: 10.1016/s1246-7820(97)80009-2
|View full text |Cite
|
Sign up to set email alerts
|

Immunohistological analysis of antibodies against ABH and other glycoconjugates in normal human pyloric and duodenal mucosae

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
7
0

Year Published

2000
2000
2018
2018

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(7 citation statements)
references
References 3 publications
0
7
0
Order By: Relevance
“…We observed that those antibodies reactive with either E. coli LMG8223 or E. coli LFMFP861 were those that have the broadest reactivity to A or B epitopes. Thus, E. coli LMG8223 showed positive reactions with anti-A antibodies #21 (42.5%) and #7 (68%), which have very strong, and broad A reactivity, but not with antibodies #3, or #5 (<1%), which have more restricted anti-A specificity ( Le Pendu et al, 1997 ). Similarly, E. coli LFMFP861 showed strong positive reaction with anti-B antibody #49 (14.3%), which has a broad reactivity with a group of B-like molecules, but showed low or no reaction with antibodies #38 (3.9%), #39 (2.7%), #40 (<1%), and #43 (3.9%), known to be more restricted anti-B ( Le Pendu et al, 1997 ).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…We observed that those antibodies reactive with either E. coli LMG8223 or E. coli LFMFP861 were those that have the broadest reactivity to A or B epitopes. Thus, E. coli LMG8223 showed positive reactions with anti-A antibodies #21 (42.5%) and #7 (68%), which have very strong, and broad A reactivity, but not with antibodies #3, or #5 (<1%), which have more restricted anti-A specificity ( Le Pendu et al, 1997 ). Similarly, E. coli LFMFP861 showed strong positive reaction with anti-B antibody #49 (14.3%), which has a broad reactivity with a group of B-like molecules, but showed low or no reaction with antibodies #38 (3.9%), #39 (2.7%), #40 (<1%), and #43 (3.9%), known to be more restricted anti-B ( Le Pendu et al, 1997 ).…”
Section: Resultsmentioning
confidence: 99%
“…A series of anti-HBGAs antibodies was used. Anti-A antibodies #3, #5, #7, #21 and anti-B antibodies #38, #39, #40, #43, #49 have been described previously ( Le Pendu et al, 1997 ). The anti-H type 3/4 Mbr1 was obtained from Enzo Life Sciences; the anti-H 19-0LE, an anti-H type 2 that shows some cross-reactivity with Le y , the anti-Le a 7-LE, the anti-Le b 2-25LE, and the anti-Le y 12-4LE were obtained from Dr. J. Bara (CNRS, Villejuif, France).…”
Section: Methodsmentioning
confidence: 99%
“…ND, not determined. , and ALe y (13). Their binding was detected as described above for antibody 10C5.…”
mentioning
confidence: 99%
“…Antibody-dependent assays were blocked with 5% nonfat dry milk (Régilait, Saint-Martin-Belle-Roche, France) diluted in PBS, while lectin assays were blocked with Synblock (AbD Serotec, Oxford, United Kingdom). The A antigen was detected using mouse monoclonal anti-A antibody (2A21), and the B antigen was detected using a specific mouse monoclonal antibody (B49) (81). H type 2 expression was determined using the horseradish peroxidase (HRP)-conjugated lectin UEA-I at 2 g/ml (Sigma-Aldrich, St. Louis, MO).…”
Section: Methodsmentioning
confidence: 99%